Advanced myelofibrosis is marked by loss of NKG2D and DNAM-1 NK activating signaling and increased TIM-3 T CD8 exhaustion
Authors
- L Marani (ORCID: https://orcid.org/0000-0003-1579-9700)
- Priscila Santos Scheucher (ORCID: https://orcid.org/0000-0003-3111-8506)
- Camila García (ORCID: https://orcid.org/0000-0002-5754-678X)
- Lorena Lôbo de Figueiredo-Pontes (ORCID: https://orcid.org/0000-0002-2139-5756)
- Leonardo Carvalho Palma (ORCID: https://orcid.org/0000-0002-3798-079X)
- Adriane Souza Lima
- Larissa Sarri Binelli
- Josiane Lilian dos Santos Schiavinato
- Mariana Medeiros (ORCID: https://orcid.org/0000-0002-7087-0146)
- RL Pacca
- Beatriz Adjafre (ORCID: https://orcid.org/0000-0002-7899-7328)
- Isabela Lefol Arruda (ORCID: https://orcid.org/0000-0003-3028-4027)
- Allana Guimarães de Carvalho (ORCID: https://orcid.org/0000-0001-6414-6218)
- Cleide L. Araujo
Institutions
- Universidade de São Paulo (BR)
- Clinics Hospital of Ribeirão Preto (BR)
Publication Details
- Journal
- Blood
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1182/blood-2025-1980
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00